
Dor Biopharma, Inc.
Get Full AccessDescription
- DOR BioPharma, Inc. ( DOR ) is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. DORs lead product, orBec® (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD), a common and potentially life-threatening complication of allogeneic hematopoietic cell transplantation.
-
Headquarters:29 Emmons Dr Ste C10 , Princeton, New Jersey, United States
More -
Phone Number: +1 609-538-8200
-
Website: https://www.dorbiopharma.com
-
Employees:30
-
Revenue:$10 - 50M
-
Legal Name:Dor Biopharma, Inc.
-
Dor Biopharma, Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 624110 |
Show More
Frequently Asked Questions regarding Dor Biopharma, Inc.
-
Where are Dor Biopharma, Inc.'s Headquarters?
Dor Biopharma, Inc.'s Headquarters are in 29 Emmons Dr Ste C10 ,Princeton,New Jersey,United States
-
What is Dor Biopharma, Inc.'s phone number?
Dor Biopharma, Inc.'s phone number is +1 609-538-8200
-
What is Dor Biopharma, Inc.'s official website?
Dor Biopharma, Inc.'s official website is https://www.dorbiopharma.com
-
What is Dor Biopharma, Inc.'s Revenue?
Dor Biopharma, Inc.'s revenue is $10 - 50M
-
What is Dor Biopharma, Inc.'s NAICS code?
Dor Biopharma, Inc.'s NAICS code is 624110
-
How many employees are working in Dor Biopharma, Inc.
Dor Biopharma, Inc. has 30 employees
-
What is Dor Biopharma, Inc.'s Industry?
Dor Biopharma, Inc. is in the industry of Biotechnology
-
Who is Dor Biopharma, Inc.'s Chief Scientific Officer?
Dor Biopharma, Inc.'s Chief Scientific Officer is Robert Brey